ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
irenekwshiu
|
154 |
48K |
5 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
48K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
irenekwshiu
|
154 |
48K |
19 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
48K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
irenekwshiu
|
154 |
48K |
8 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
48K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
irenekwshiu
|
154 |
48K |
30 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
48K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
irenekwshiu
|
549 |
178K |
9 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
549
|
178K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
irenekwshiu
|
549 |
178K |
8 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
549
|
178K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
irenekwshiu
|
549 |
178K |
5 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
549
|
178K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
irenekwshiu
|
549 |
178K |
13 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
549
|
178K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
irenekwshiu
|
549 |
178K |
5 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
549
|
178K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
irenekwshiu
|
549 |
178K |
4 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
549
|
178K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
irenekwshiu
|
549 |
178K |
14 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
549
|
178K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
irenekwshiu
|
549 |
178K |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
549
|
178K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
irenekwshiu
|
549 |
178K |
2 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
549
|
178K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
What happens if there is attempt to take over?
|
|
irenekwshiu
|
16 |
6.1K |
2 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
16
|
6.1K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
What happens if there is attempt to take over?
|
|
irenekwshiu
|
16 |
6.1K |
7 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
16
|
6.1K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
irenekwshiu
|
549 |
178K |
6 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
549
|
178K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
irenekwshiu
|
5.4K |
2.6M |
7 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
5.4K
|
2.6M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
irenekwshiu
|
5.4K |
2.6M |
20 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
5.4K
|
2.6M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
irenekwshiu
|
549 |
178K |
33 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
178K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
irenekwshiu
|
17K |
6.7M |
7 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
irenekwshiu
|
549 |
178K |
16 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
178K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
News: MSB Mesoblast Says US FDA Supports Accelerated Approval Pathway For Rexlemestrocel-L
|
|
irenekwshiu
|
1 |
637 |
10 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
1
|
637
|
10
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
irenekwshiu
|
608 |
245K |
9 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
608
|
245K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
irenekwshiu
|
608 |
245K |
4 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
608
|
245K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
irenekwshiu
|
608 |
245K |
31 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
608
|
245K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
irenekwshiu
|
608 |
245K |
27 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
608
|
245K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
irenekwshiu
|
17K |
6.7M |
5 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
irenekwshiu
|
17K |
6.7M |
1 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
irenekwshiu
|
608 |
245K |
8 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
608
|
245K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
irenekwshiu
|
608 |
245K |
12 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
608
|
245K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
irenekwshiu
|
608 |
245K |
31 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
608
|
245K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Financial Results Presentation
|
|
irenekwshiu
|
78 |
25K |
19 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
78
|
25K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Financial Results Presentation
|
|
irenekwshiu
|
78 |
25K |
14 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
78
|
25K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Financial Results Presentation
|
|
irenekwshiu
|
78 |
25K |
35 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
78
|
25K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
irenekwshiu
|
362 |
119K |
10 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
362
|
119K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Clinical Trial-HF
|
|
irenekwshiu
|
14 |
5.7K |
6 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
14
|
5.7K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Clinical Trial-HF
|
|
irenekwshiu
|
14 |
5.7K |
19 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
14
|
5.7K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
irenekwshiu
|
17K |
6.7M |
1 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
irenekwshiu
|
17K |
6.7M |
23 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
17K
|
6.7M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
irenekwshiu
|
362 |
119K |
31 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
362
|
119K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
irenekwshiu
|
362 |
119K |
5 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
362
|
119K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
irenekwshiu
|
362 |
119K |
27 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
362
|
119K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
irenekwshiu
|
9.8K |
2.9M |
20 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
irenekwshiu
|
9.8K |
2.9M |
50 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
50
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
irenekwshiu
|
9.8K |
2.9M |
8 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
irenekwshiu
|
9.8K |
2.9M |
3 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
irenekwshiu
|
9.8K |
2.9M |
8 |
07/01/24 |
07/01/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
irenekwshiu
|
9.8K |
2.9M |
23 |
07/01/24 |
07/01/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
irenekwshiu
|
9.8K |
2.9M |
3 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
9.8K
|
2.9M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
irenekwshiu
|
512 |
128K |
15 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
512
|
128K
|
15
|
|